Gene · 5266
Papers4,558
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,558
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Engineered bone marrow as a clinically relevant ex vivo model for primary bone cancer research and drug screening. | Proc Natl Acad Sci U S A | 2023 | 37729195 | PubTator, text mining | PubMed |
| The role of microRNAs in neurobiology and pathophysiology of the hippocampus. | Front Mol Neurosci | 2023 | 37727513 | PubTator, text mining | PubMed |
| Integrating synthetic accessibility with AI-based generative drug design. | J Cheminform | 2023 | 37726842 | PubTator, text mining | PubMed |
| Cell-free therapy based on extracellular vesicles: a promising therapeutic strategy for peripheral nerve injury. | Stem Cell Res Ther | 2023 | 37726794 | PubTator, text mining | PubMed |
| The discovery, structure, and function of 5-HTR1E serotonin receptor. | Cell Commun Signal | 2023 | 37723479 | PubTator, text mining | PubMed |
| Study of Serum Apelin and Insulin Resistance in Type 2 Diabetes Mellitus Patients With or Without Obesity. | Cureus | 2023 | 37706122 | PubTator, text mining | PubMed |
| CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease. | Nat Commun | 2023 | 37704597 | PubTator, text mining | PubMed |
| A diagnostic model for sepsis-induced acute lung injury using a consensus machine learning approach and its therapeutic implications. | J Transl Med | 2023 | 37700323 | PubTator, text mining | PubMed |
| Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma. | Sci Rep | 2023 | 37700026 | PubTator, text mining | PubMed |
| Therapeutic effects of medicinal plants and their constituents on lung cancer, in vitro, in vivo and clinical evidence. | J Cell Mol Med | 2023 | 37697969 | PubTator, text mining | PubMed |
| Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer. | Ther Adv Med Oncol | 2023 | 37692364 | PubTator, text mining | PubMed |
| Spice-Derived Phenolic Compounds: Potential for Skin Cancer Prevention and Therapy. | Molecules | 2023 | 37687080 | PubTator, text mining | PubMed |
| Overview on the Polyphenol Avenanthramide in Oats (Avena sativa Linn.) as Regulators of PI3K Signaling in the Management of Neurodegenerative Diseases. | Nutrients | 2023 | 37686782 | PubTator, text mining | PubMed |
| The Three-Dimensional In Vitro Cell Culture Models in the Study of Oral Cancer Immune Microenvironment. | Cancers (Basel) | 2023 | 37686542 | PubTator, text mining | PubMed |
| Novel CSF biomarkers for diagnosis and integrated analysis of neuropsychiatric systemic lupus erythematosus: based on antibody profiling. | Arthritis Res Ther | 2023 | 37684700 | PubTator, text mining | PubMed |
| Mitigating Sarcopenia with Diet and Exercise. | Int J Environ Res Public Health | 2023 | 37681791 | PubTator, text mining | PubMed |
| Fibroblast growth factor receptors as targets for anticancer therapy in cholangiocarcinomas and urothelial carcinomas. | Heliyon | 2023 | 37681152 | PubTator, text mining | PubMed |
| Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment. | Front Pharmacol | 2023 | 37680708 | PubTator, text mining | PubMed |
| Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer. | Cancer Discov | 2023 | 37676710 | PubTator, text mining | PubMed |
| Cantharidin induces apoptosis of human triple negative breast cancer cells through mir-607-mediated downregulation of EGFR. | J Transl Med | 2023 | 37670360 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5266/papers?page=16